Graf Akcie DRNA (Dicerna Pharmaceuticals Inc). Diskuze k akciím DRNA. Aktuální informace DRNA.

Základní informace o společnosti Dicerna Pharmaceuticals Inc (Akcie DRNA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1.65B
Hodnota podniku (EV) N/A
Tržby 178.771M
EBITDA N/A
Zisk -129.22
Růst v tržbách Q/Q 2.20 %
Růst v tržbách Y/Y 99.54 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -0.52
EV/Sales 6.04
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 8.98
P/FCF 143.13
Price/Book 11.65
Účetní hodnota na akcii 1.82
Hotovost na akcii 7.53
FCF vůči ceně 0.70 %
Počet zaměstnanců 302
Tržba na zaměstnance 591.957k
Profit margin -68.62 %
Operating margin -69.31 %
Gross margin 100.00 %
EBIT margin -71.96 %
EBITDA margin -97.32 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 23.26 %
EPS - Očekávaný růst příští rok 58.62 %
Return on assets -17.75 %
Return on equity -97.72 %
ROIC -17.27 %
ROCE -20.39 %
Dluhy/Equity 4.14
Čistý dluh/EBITDA 17.67
Current ratio 2.97
Quick Ratio 2.97
Volatilita 4.07
Beta 0.90
RSI 52.19
Cílová cena analytiků 35
Známka akcie (dle analytiků) 1.09
Insider ownership 7.24 %
Institutional ownership 84.67 %
Počet akcií 77.734M
Procento shortovaných akcií 6.90 %
Short ratio 7.04 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země United States

Finanční výsledky akcie DRNA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$23.904$6.176$1.03-$0.184-
Cost Of Goods Sold------
Gross Profit$23.904$6.176$1.03-$0.184-
Research And Development Expenses$109.339$45.711$35.888$41.399$43.971$29.453
SG&A Expenses$42.751$21.685$16.838$15.433$19.24$15.648
Other Operating Income Or Expenses-$-29.132$-9.043$-2.916--
Operating Expenses$152.09$96.528$61.769$59.748$63.211$45.101
Operating Income$-128.186$-90.352$-60.739$-59.748$-63.027$-45.101
Total Non-Operating Income/Expense$7.727$1.499$0.539$0.235$0.188$-2.838
Pre-Tax Income$-120.459$-88.853$-60.2$-59.513$-62.839$-47.939
Income Taxes------
Income After Taxes$-120.459$-88.853$-60.2$-59.513$-62.839$-47.939
Other Income------
Income From Continuous Operations$-120.459$-88.853$-60.2$-59.513$-62.839$-47.939
Income From Discontinued Operations------
Net Income$-120.459$-88.853$-80.292$-59.513$-62.839$-48.143
EBITDA$-130.491$-90.704$-60.13$-58.835$-62.166$-44.253
EBIT$-128.186$-90.352$-60.739$-59.748$-63.027$-45.101
Basic Shares Outstanding685622212016
Shares Outstanding685622212016
Basic EPS$-1.76$-1.60$-3.66$-2.87$-3.09$-3.00
EPS - Earnings Per Share$-1.76$-1.60$-3.66$-2.87$-3.09$-3.00
# 2020 2019 2018 2017 2016 2015
Current Ratio2.30074.31157.05314.761610.681218.8634
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin100100100-100-
Operating Margin-536.2534-1462.953-5896.99--34253.8-
EBIT Margin-536.2534-1462.953-5896.99--34253.8-
EBITDA Margin-545.8961-1468.653-5837.864--33785.87-
Pre-Tax Profit Margin-503.9282-1438.682-5844.661--34151.63-
Net Profit Margin-503.9282-1438.682-7795.34--34151.63-
Asset Turnover0.040.01510.0085-0.0018-
Inventory Turnover Ratio------
Receiveable Turnover0.11930.06180.6507---
Days Sales In Receivables3059.2885909.974560.966---
ROE - Return On Equity-79.1478-44.2731-59.5533-144.4209-69.0372-48.7482
Return On Tangible Equity-79.1478-44.2731-59.5533-144.421-69.0372-48.7482
ROA - Return On Assets-20.1636-21.7223-49.7513-116.1184-62.8246-46.2709
ROI - Return On Investment-79.1478-44.2731-59.5533-144.421-69.0372-48.7482
Book Value Per Share2.12642.94221.95732.00094.41965.5288
Operating Cash Flow Per Share-0.33912.39710.28460.0487-0.2381369.2856
Free Cash Flow Per Share-0.42552.39680.30010.0829-0.1686383.1779

Porovnání s konkurencí: Akcie DRNA

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
DRNA 0.00 N/A 99.54 % 58.62 % -97.72 % 11.65 -68.62 %
Akcie AMGN 20.99 1.66 4.87 % -2.29 % 60.57 % 12.44 28.57 %
Akcie ALNY N/A N/A 99.18 % -27.98 % -88.43 % 23.92 -174.15 %
Akcie ARWR N/A N/A -12.95 % -79.17 % -28.00 % 15.06 -96.09 %
Akcie MRK 35.60 1.38 2.87 % 13.14 % 19.42 % 7.90 14.72 %
Akcie PFE 17.66 1.97 4.96 % 50.00 % 19.81 % 3.72 22.95 %
Akcie RGLS 0.00 N/A N/A % 100.00 % -60.96 % 1.40 -157.21 %
Akcie RGLS 0.00 N/A N/A % 100.00 % -60.96 % 1.40 -157.21 %

Nedávné obchody insiderů: Akcie DRNA

Jméno Obchod Cena Objem
Bob D Brown
Chief Scientific Ofr., EVP R, and D
Option
8 Jan 2021
$23.29 $201,459
Regina M. Paglia
Chief Human Resources Officer
Option
8 Jan 2021
$23.29 $67,541
Douglas Fambrough
President and CEO
Option
8 Jan 2021
$23.29 $464,636
James B Weissman
Chief Operating Officer and EVP
Option
8 Jan 2021
$23.29 $201,459
Bob D Brown
Chief Scientific Ofr., EVP R, and D
Prodej
12 Jan 2021
$24.07 $139,799
James B Weissman
Chief Operating Officer and EVP
Prodej
12 Jan 2021
$24.08 $139,857
Regina M. Paglia
Chief Human Resources Officer
Prodej
25 Jan 2021
$25.00 $158,150
Bob D Brown
Chief Scientific Ofr., EVP R, and D
Prodej
25 Jan 2021
$25.00 $540,750
Regina M. Paglia
Chief Human Resources Officer
Option
2 Feb 2021
$12.93 $57,293
Bob D Brown
Chief Scientific Ofr., EVP R, and D
Option
3 Feb 2021
$9.09 $75,556
James B Weissman
Chief Operating Officer and EVP
Prodej
5 Feb 2021
$26.99 $193,140

Diskuze k akciím DRNA